Related references
Note: Only part of the references are listed.Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome
Katsunori Imai et al.
ANNALS OF SURGERY (2019)
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert et al.
JAMA ONCOLOGY (2019)
Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection
Wei Liu et al.
EJSO (2019)
Beppu's Nomogram Score Is an Independent Prognostic Factor for Colorectal Liver Metastasis Receiving Perioperative Chemotherapy and/or Targeted Therapy
Akio Higuchi et al.
IN VIVO (2019)
Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
Dimitrios Moris et al.
WORLD JOURNAL OF SURGERY (2018)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Short Chemotherapy-Free Interval Improves Oncological Outcome in Patients Undergoing Two-Stage Hepatectomy for Colorectal Liver Metastases
P. Kambakamba et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases
Emily Khoo et al.
HPB (2016)
The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
Wei Liu et al.
ONCOTARGET (2016)
Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival
Lars Thomas Seeberg et al.
ANNALS OF SURGERY (2015)
Behind the Numbers: Inverse Probability Weighting
Elkan F. Halpern
RADIOLOGY (2014)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Toru Beppu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?
Rene Adam et al.
ANNALS OF SURGERY (2010)
Neoadjuvant Strategies for the Treatment of Locally Advanced Esophageal Cancer
John R. Hyngstrom et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Neoadjuvant Therapy of Locally Advanced Gastric Cancer
James J. Mezhir et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
Emmanuel Mitry et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
TM Pawlik et al.
ANNALS OF SURGERY (2005)
Share Paper
